Your browser doesn't support javascript.
loading
p53 cooperates with SIRT6 to regulate cardiolipin de novo biosynthesis.
Li, Meiting; Hou, Tianyun; Gao, Tian; Lu, Xiaopeng; Yang, Qiaoyan; Zhu, Qian; Li, Zhiming; Liu, Chaohua; Mu, Guanqun; Liu, Ge; Bao, Yantao; Wen, He; Wang, Lina; Wang, Haiying; Zhao, Ying; Gu, Wei; Yang, Yang; Zhu, Wei-Guo.
Afiliação
  • Li M; Key Laboratory of Carcinogenesis and Translational Research (Ministry of Education), Beijing Key Laboratory of Protein Posttranslational Modifications and Cell Function, Department of Biochemistry and Molecular Biology, School of Basic Medical Sciences, Peking University Health Science Center, 38 Xu
  • Hou T; Key Laboratory of Carcinogenesis and Translational Research (Ministry of Education), Beijing Key Laboratory of Protein Posttranslational Modifications and Cell Function, Department of Biochemistry and Molecular Biology, School of Basic Medical Sciences, Peking University Health Science Center, 38 Xu
  • Gao T; Key Laboratory of Carcinogenesis and Translational Research (Ministry of Education), Beijing Key Laboratory of Protein Posttranslational Modifications and Cell Function, Department of Biochemistry and Molecular Biology, School of Basic Medical Sciences, Peking University Health Science Center, 38 Xu
  • Lu X; Guangdong Key Laboratory for Genome Stability and Human Disease Prevention, Carson cancer research center, Department of Biochemistry and Molecular Biology, School of Medicine, Shenzhen University, Shenzhen, 516080, China.
  • Yang Q; Key Laboratory of Carcinogenesis and Translational Research (Ministry of Education), Beijing Key Laboratory of Protein Posttranslational Modifications and Cell Function, Department of Biochemistry and Molecular Biology, School of Basic Medical Sciences, Peking University Health Science Center, 38 Xu
  • Zhu Q; Guangdong Key Laboratory for Genome Stability and Human Disease Prevention, Carson cancer research center, Department of Biochemistry and Molecular Biology, School of Medicine, Shenzhen University, Shenzhen, 516080, China.
  • Li Z; Key Laboratory of Carcinogenesis and Translational Research (Ministry of Education), Beijing Key Laboratory of Protein Posttranslational Modifications and Cell Function, Department of Biochemistry and Molecular Biology, School of Basic Medical Sciences, Peking University Health Science Center, 38 Xu
  • Liu C; Key Laboratory of Carcinogenesis and Translational Research (Ministry of Education), Beijing Key Laboratory of Protein Posttranslational Modifications and Cell Function, Department of Biochemistry and Molecular Biology, School of Basic Medical Sciences, Peking University Health Science Center, 38 Xu
  • Mu G; Key Laboratory of Carcinogenesis and Translational Research (Ministry of Education), Beijing Key Laboratory of Protein Posttranslational Modifications and Cell Function, Department of Biochemistry and Molecular Biology, School of Basic Medical Sciences, Peking University Health Science Center, 38 Xu
  • Liu G; Guangdong Key Laboratory for Genome Stability and Human Disease Prevention, Carson cancer research center, Department of Biochemistry and Molecular Biology, School of Medicine, Shenzhen University, Shenzhen, 516080, China.
  • Bao Y; Guangdong Key Laboratory for Genome Stability and Human Disease Prevention, Carson cancer research center, Department of Biochemistry and Molecular Biology, School of Medicine, Shenzhen University, Shenzhen, 516080, China.
  • Wen H; Guangdong Key Laboratory for Genome Stability and Human Disease Prevention, Carson cancer research center, Department of Biochemistry and Molecular Biology, School of Medicine, Shenzhen University, Shenzhen, 516080, China.
  • Wang L; Key Laboratory of Carcinogenesis and Translational Research (Ministry of Education), Beijing Key Laboratory of Protein Posttranslational Modifications and Cell Function, Department of Biochemistry and Molecular Biology, School of Basic Medical Sciences, Peking University Health Science Center, 38 Xu
  • Wang H; Key Laboratory of Carcinogenesis and Translational Research (Ministry of Education), Beijing Key Laboratory of Protein Posttranslational Modifications and Cell Function, Department of Biochemistry and Molecular Biology, School of Basic Medical Sciences, Peking University Health Science Center, 38 Xu
  • Zhao Y; Key Laboratory of Carcinogenesis and Translational Research (Ministry of Education), Beijing Key Laboratory of Protein Posttranslational Modifications and Cell Function, Department of Biochemistry and Molecular Biology, School of Basic Medical Sciences, Peking University Health Science Center, 38 Xu
  • Gu W; Institute for Cancer Genetics, Department of Pathology and Cell Biology, Herbert Irving Comprehensive Cancer Center, College of Physicians & Surgeons, Columbia University, 1130 Nicholas Ave, New York, NY, 10032, USA.
  • Yang Y; Key Laboratory of Carcinogenesis and Translational Research (Ministry of Education), Beijing Key Laboratory of Protein Posttranslational Modifications and Cell Function, Department of Biochemistry and Molecular Biology, School of Basic Medical Sciences, Peking University Health Science Center, 38 Xu
  • Zhu WG; Key Laboratory of Carcinogenesis and Translational Research (Ministry of Education), Beijing Key Laboratory of Protein Posttranslational Modifications and Cell Function, Department of Biochemistry and Molecular Biology, School of Basic Medical Sciences, Peking University Health Science Center, 38 Xu
Cell Death Dis ; 9(10): 941, 2018 09 20.
Article em En | MEDLINE | ID: mdl-30237540
The tumor suppressor p53 has critical roles in regulating lipid metabolism, but whether and how p53 regulates cardiolipin (CL) de novo biosynthesis is unknown. Here, we report that p53 physically interacts with histone deacetylase SIRT6 in vitro and in vivo, and this interaction increases following palmitic acid (PA) treatment. In response to PA, p53 and SIRT6 localize to chromatin in a p53-dependent manner. Chromatin p53 and SIRT6 bind the promoters of CDP-diacylglycerol synthase 1 and 2 (CDS1 and CDS2), two enzymes required to catalyze CL de novo biosynthesis. Here, SIRT6 serves as a co-activator of p53 and effectively recruits RNA polymerase II to the CDS1 and CDS2 promoters to enhance CL de novo biosynthesis. Our findings reveal a novel, cooperative model executed by p53 and SIRT6 to maintain lipid homeostasis.
Assuntos

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Cardiolipinas / Proteína Supressora de Tumor p53 / Sirtuínas Tipo de estudo: Prognostic_studies Limite: Humans Idioma: En Ano de publicação: 2018 Tipo de documento: Article

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Cardiolipinas / Proteína Supressora de Tumor p53 / Sirtuínas Tipo de estudo: Prognostic_studies Limite: Humans Idioma: En Ano de publicação: 2018 Tipo de documento: Article